on 05 Mar 2024
Last Applicant/ Owned by
NL-3818 LE Amersfoort
NL
Serial Number
79357252 filed on 23rd Mar 2022
Registration Number
7318328 registered on 05th Mar 2024
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
Chemical and organic compositions for use in the manufacture of pharmaceuticals; chemical and organic excipients for use in the manufacture of food and beverages; chemical and organic compositions for use in the manufacture of food and beverages; lactose as a raw material to be used in the manufacture of foodstuffs; lactose for the food industry; lactose for industrial purposes; plant extracts forRead More
Coffee, tea and herbal tea-based beverages, cocoa-based beverages, chocolate-based beverages, chocolate-based beverages with milk; rice pudding; semolina-based products, namely, semolina pudding, oatmeal porridge, groats for human food; sauces, cream-based sauces and butter-based sauces; dessert puddings, Bavarian cream, chocolate mousse; custard; desserts included in this class, namely, tiramisu, crème brûlée, crème caramel; powders and preparations for making cappuccino, cocoa, chocolate, coffee and tea beverages
beverages containing primarily dairy or of plant- or nut-based dairy substitutes, namely, dairy-based beverages, plant-based milk substitute and nut milk-based beverages; dairy products for dietetic use other than for medical use, namely, lactose-free milk, lactose-free cheese, low-fat milk, low-fat cheese; dairy-based spreads for bread; milk; fermented dairy products, namely, fermented milk; milk powder; condensed milk; evaporated milk; buttermilk; protein milk; yogurt and yogurt products, namely, yogurt drinks, Greek yogurt; cottage cheese, soft white cheese; quark; cheese and cheese products, namely, cheese spreads, cheese dips; cream, whipped cream, sour cream, coffee creamer; plant- and nut-based substitutes for cheese, cream, whipped cream and coffee creamer; edible oils and fats; butter, butter ghee; desserts based on dairy or on plant- or nut-based milk substitutes, namely, dairy-based chocolate food beverages, plant-based milk substitute and nut milk-based chocolate food beverages; dairy-based meat substitutes; breakfast drinks consisting primarily of dairy products, plant-based dairy replacements or nut based dairy replacements, namely, dairy-based breakfast drinks, plant-based milk substitute and nut milk-based breakfast drinks; snacks based on dairy products, plant-based dairy replacements or nut based dairy replacements, namely, snacks consisting of primarily dairy-based meat; dairy substitutes, namely, non-dairy milk substitutes; dairy product substitutes, namely, artificial cream; plant-based dairy substitutes, namely, plant-based milk substitutes; nut-based dairy substitutes, namely, nut-based milk substitutes; panna cotta
Pharmaceuticals, namely, pharmaceuticals for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; biological preparations for pharmaceutical purposes, namely, biological preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; biological preparations for medical purposes, namely, biological preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; hyaluronic acids for pharmaceutical purposes; hyaluronic acids for medical purposes; amino acids for pharmaceutical purposes; amino acids for medical purposes; lactose for pharmaceutical purposes; lactose for medical purposes; cellulose esters for pharmaceutical purposes; microcrystalline cellulose for pharmaceutical purposes; nutraceuticals for use as a dietary supplement; nutraceuticals for therapeutic purposes; food supplements; dietary food supplements; vitamin preparations in the nature of food supplements; dietary supplements in form of vitamins and minerals; dietetic preparations and beverages adapted for medical purposes; food for babies; milk powder for infants, namely, powdered milk for babies; infant formula milk powder, namely, powdered milk for babies
Chemical and organic compositions for use in the manufacture of pharmaceuticals; chemical and organic excipients for use in the manufacture of food and beverages; chemical and organic compositions for use in the manufacture of food and beverages; lactose as a raw material to be used in the manufacture of foodstuffs; lactose for the food industry; lactose for industrial purposes; plant extracts for use in food and beverage industry; food protein as a raw material for the food industry; plant proteins as a raw material for the food industry; plant proteins in powder form for industrial purposes; proteins for industrial purposes; casein and caseinates for industrial purposes; protein from pulses for use as an ingredient in the manufacture of dietary supplements
No 79357252
No Service/Collective Mark
No T271189WUS
No
No
No
No
Yes
Yes
No
No
| Status Date | Action Taken |
|---|---|
| 05th Mar 2024 | REGISTERED-PRINCIPAL REGISTER |
| 05th Mar 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 02th Jan 2024 | NOTIFICATION PROCESSED BY IB |
| 19th Dec 2023 | PUBLISHED FOR OPPOSITION |
| 19th Dec 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 29th Nov 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 29th Nov 2023 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| 29th Nov 2023 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| 27th Nov 2023 | CORRECTION CREATED FOR IB |
| 27th Nov 2023 | CORRECTION SENT TO IB |
